Inhibition of allergic responsiveness in a murine asthma model via IFN-γ transgene expression

Chinese Medical Journal

Volumn 115, Issue 10, 2002, Pages 1470-1474

  Gao, Zhancheng ^a   Kang, Yu ^a   Xu, Yu ^a   Shang, Ying ^a   Gai, Jun ^a   He, Quanying ^a  

^a PEKING UNIVERSITY PEOPLE S HOSPITAL   (China)

Author keywords

Adenoviral vector; Asthma; Gene therapy; Interferon type II

Indexed keywords

ADENOVIRUS VECTOR; BETA GALACTOSIDASE; GAMMA INTERFERON; NOSE DROPS; OVALBUMIN;

ALLERGIC ASTHMA; ALLERGIC REACTION; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; EOSINOPHIL; GENE EXPRESSION; GENE OVEREXPRESSION; GENE THERAPY; GENETIC TRANSDUCTION; HISTOLOGY; IMMUNOGENETICS; IN VITRO STUDY; IN VIVO STUDY; LUNG INFILTRATE; MALE; MARKER GENE; MOUSE; NONHUMAN; PLAQUE FORMING CELL; RESPIRATORY EPITHELIUM; STATISTICAL SIGNIFICANCE; TRACHEOBRONCHIAL TOILET; TRANSGENE;

ADENOVIRIDAE; ANIMALS; ASTHMA; DISEASE MODELS, ANIMAL; EOSINOPHILIA; GENE THERAPY; INTERFERON TYPE II; LUNG; MALE; MICE; MICE, INBRED C57BL; OVALBUMIN; TRANSGENES;

EID: 0036805431     PISSN: 03666999     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (13)

1. Romagnani S. Regulation of the development of type 2 T-helper cells in allergy. Curr Opin Immunol 1994;6:838-846.
2. Bogniewicz M, Martin RJ, Martin D, et al. The effects of nebulized recombinant interferon-gamma in asthmatic airways. J Allergy Clin Immunol 1995;95:133-135.
3. Lack G, Bradley KL, Hamelmann E, et al. Nebulized IFN-γ inhibits the development of secondary allergic responses in mice. J Immunol 1996;157:1432-1439.
4. Zeitlin PL. Cystic fibrosis gene therapy trails and tribulations. Mol Ther 2000;1:5-6.
5. Dubinett SM, Miller PW, Sharma S, et al. Gene therapy for lung cancer. Hematol Oncol Clin North Am 1998;12:569-594.
6. Gao ZC, Kang Y, Shang Y, et al. Inhibition action IFN-γ transgene on murine, plaque infilfration eosinophils induces by allergen. J Peking Univ 2000;32:395-399.
7. Dong JY, Wang D, Van Ginkel FW, et al. Systematic analysis of repeated gene delivery into animal lungs with a recombinant adenovirus vector. Human Gene Therapy 1996;7:319-331.
8. + T cell in the development of airway hyperresponsiveness in a murine model of airway sensitization. J Exp Med 1996; 183: 1719-1729.
9. Cohn L, Herrick C, Niu N, et al. IL-4 promotes airway eosinophilia by suppressing IFN-gamma production: defining a novel role for IFN-gamma in the regulation of allergic airway inflammation. J Immunol 2001;166:2760-2767.
10. Mehlotra RK, Hall LR, Haxhiu MA, et al. Reciprocal immunomodulatory effects of gamma interferon and interleukin-4 on filaria-induced airway hyperresponsiveness. Infect Immunol 2001;69:1463-1468.
11. Krasnowska M, Medrala W, Malolepszy J, et al. Effect of recombinant IFN-gamma on igE-dependent leukotriene generation by peripheral blood leukocytes in patients with pollinosis and asthma. Arch Immunol Ther Exp (Warsz) 2000;48:287-292.
12. Tang C, Inman MD, van Rooijen N, et al. Th type 1-stimulating activity of lung macrophages inhibits Th2-mediated allergic airway inflammation by an IFN-gamma-dependent mechanism. J Immunol 2001;166:1471-1481.
13. von Hertzen LC, Haahtela T. Could the risk of asthma and atopy be reduced by a vaccine that induces a strong T-helper type 1 response? Am J Respir Cell Mol Biol 2000;22:139-142.